These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30070412)

  • 21. Improved Hepatic Reserve and Fibrosis in a Case of "Portal-Systemic Liver Failure" by Portosystemic Shunt Occlusion.
    Ishikawa T; Sasaki R; Nishimura T; Iwamoto T; Takami T; Yamasaki T; Sakaida I
    Am J Case Rep; 2020 Feb; 21():e921236. PubMed ID: 32063601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic effect of balloon-occluded retrograde transvenous obliteration on portal-systemic encephalopathy in patients with liver cirrhosis.
    Kato T; Uematsu T; Nishigaki Y; Sugihara J; Tomita E; Moriwaki H
    Intern Med; 2001 Aug; 40(8):688-91. PubMed ID: 11518103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Balloon Retrograde Transvenous Obliteration Versus Endoscopic Cyanoacrylate in Bleeding Gastric Varices: Comparison of Rebleeding and Mortality with Extended Follow-up.
    Stein DJ; Salinas C; Sabri S; Onyeali R; Caldwell S; Henry Z
    J Vasc Interv Radiol; 2019 Feb; 30(2):187-194. PubMed ID: 30717949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Change in Portal Pressure and Clinical Outcome in Cirrhotic Patients with Gastric Varices after Plug-Assisted Retrograde Transvenous Obliteration.
    Park JW; Yoo JJ; Kim SG; Jeong SW; Jang JY; Lee SH; Kim HS; Lee JM; Shim JJ; Kim YD; Cheon GJ; Jun BG; Kim YS
    Gut Liver; 2020 Nov; 14(6):783-791. PubMed ID: 32050751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis.
    Lee SJ; Kim SU; Kim MD; Kim YH; Kim GM; Park SI; Won JY; Lee DY; Lee KH
    J Gastroenterol Hepatol; 2017 Aug; 32(8):1487-1494. PubMed ID: 28085232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt.
    Choi YH; Yoon CJ; Park JH; Chung JW; Kwon JW; Choi GM
    Korean J Radiol; 2003; 4(2):109-16. PubMed ID: 12845306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The conventional balloon-occluded retrograde transvenous obliteration procedure: indications, contraindications, and technical applications.
    Saad WE; Kitanosono T; Koizumi J; Hirota S
    Tech Vasc Interv Radiol; 2013 Jun; 16(2):101-51. PubMed ID: 23830671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Balloon-occluded retrograde transvenous obliteration of gastric varices: conception, evolution, and history.
    Saad WE; Khaja MS; Hirota S
    Tech Vasc Interv Radiol; 2012 Sep; 15(3):160-4. PubMed ID: 23021830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of balloon-occluded transvenous obliteration of gastric varices and gastrorenal shunts on the hepatic synthetic function: a comparison between Child-Pugh and model for end-stage liver disease scores.
    Saad WE; Wagner CC; Al-Osaimi A; Bliebel W; Lippert A; Davies MG; Sabri SS; Turba UC; Matsumoto AH; Angle JF; Caldwell S
    Vasc Endovascular Surg; 2013 May; 47(4):281-7. PubMed ID: 23681780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Balloon-occluded antegrade transvenous obliteration with or without balloon-occluded retrograde transvenous obliteration for the management of gastric varices: concept and technical applications.
    Saad WE; Kitanosono T; Koizumi J
    Tech Vasc Interv Radiol; 2012 Sep; 15(3):203-25. PubMed ID: 23021832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Balloon-occluded retrograde transvenous obliteration: one step beyond obliteration of gastric varices.
    Kawanaka H
    J Gastroenterol Hepatol; 2012 Jan; 27(1):3-4. PubMed ID: 22188023
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment outcomes after splenectomy with gastric devascularization or balloon-occluded retrograde transvenous obliteration for gastric varices: a propensity score-weighted analysis from a single institution.
    Oshita K; Ohira M; Honmyo N; Kobayashi T; Murakami E; Aikata H; Baba Y; Kawano R; Awai K; Chayama K; Ohdan H
    J Gastroenterol; 2020 Sep; 55(9):877-887. PubMed ID: 32533300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous use of plug-assisted and coil-assisted retrograde transvenous obliteration for treating refractory hepatic encephalopathy in a patient with two portosystemic shunts: A case report.
    Ju SG; Lee JM; Shim J
    Medicine (Baltimore); 2023 Jun; 102(22):e33961. PubMed ID: 37266629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent development of balloon-occluded retrograde transvenous obliteration.
    Kobayakawa M; Ohnishi S; Suzuki H
    J Gastroenterol Hepatol; 2019 Mar; 34(3):495-500. PubMed ID: 30170340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Balloon-occluded retrograde transvenous obliteration for intractable gastric variceal bleeding.
    Liang TJ; Chen YC; Liang HL; Liu SI; Chang PM
    J Formos Med Assoc; 2013 Jul; 112(7):426-9. PubMed ID: 23927983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver and spleen stiffness on ultrasound elastography are predictors of the occurrence of esophagogastric varices after balloon-occluded retrograde transvenous obliteration.
    Furuichi Y; Abe M; Yoshimasu Y; Takeuchi H; Itoi T
    J Hepatobiliary Pancreat Sci; 2022 Jun; 29(6):713-722. PubMed ID: 35301809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Balloon-occluded retrograde transvenous obliteration (BRTO) for a direct shunt between the inferior mesenteric vein and the inferior vena cava in a patient with hepatic encephalopathy.
    Ibukuro K; Sugihara T; Tanaka R; Fukuda H; Abe S; Tobe K; Tateishi R; Tagawa K
    J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):121-5. PubMed ID: 17296712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Non-invasive assessment of portal hypertension in patients with liver cirrhosis using FibroScan transient elastography].
    Liu F; Li TH; Han T; Xiang HL; Zhang HS
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):840-4. PubMed ID: 24331694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.
    Praktiknjo M; Simón-Talero M; Römer J; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Maurer MH; Zipprich A; Triolo M; Maleux G; Fialla AD; Dam C; Vidal-González J; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; López M; Jansen C; Chang J; Schierwagen R; Uschner F; Kukuk G; Meyer C; Thomas D; Wolter K; Strassburg CP; Laleman W; La Mura V; Ripoll C; Berzigotti A; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Krag A; Genescà J; Trebicka J;
    J Hepatol; 2020 Jun; 72(6):1140-1150. PubMed ID: 31954206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Balloon-Occluded Retrograde Transvenous Obliteration versus Transjugular Intrahepatic Portosystemic Shunt for the Management of Gastric Variceal Bleeding.
    Gimm G; Chang Y; Kim HC; Shin A; Cho EJ; Lee JH; Yu SJ; Yoon JH; Kim YJ
    Gut Liver; 2018 Nov; 12(6):704-713. PubMed ID: 29938456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.